Overview

Probiotics in PBC Patients of Poor Response to UDCA

Status:
Not yet recruiting
Trial end date:
2021-08-31
Target enrollment:
Participant gender:
Summary
The safety and efficacy of probiotics in primary biliary cholangitis (PBC) patients with poor ursodeoxycholic acid (UDCA) response.
Phase:
Phase 2
Details
Lead Sponsor:
Sun Yat-sen University
Treatments:
Ursodeoxycholic Acid